A study of the transient increase in blood fibrinolytic activity during haemodialysis

[1]  J. Jespersen.  The Diurnal Increase in Euglobulin Fibrinolytic Activity in Women Using Oral Contraceptives and in Normal Women, and the Generation of Intrinsic Fibrinolytic Activity , 1986, Thrombosis and Haemostasis.

[2]  J. Jespersen,et al.  Increased Euglobulin Fibrinolytic Potential in Women on Oral Contraceptives Low in Oestrogen – Levels of Extrinsic and Intrinsic Plasminogen Activators, Prekallikrein, Factor XII, and C1-Inactivator , 1985, Thrombosis and Haemostasis.

[3]  R. Lerner,et al.  Changes in fibrinolytic activity during the course of a single hemodialysis session. , 1985, Clinical nephrology.

[4]  J. Jespersen,et al.  A Functional Plasminogen Assay Utilizing the Potentiating Effect of Fibrinogen to Correct for the Overestimation of Plasminogen in Pathological Plasma Samples , 1985, Thrombosis and Haemostasis.

[5]  D. Hoppensteadt,et al.  Studies on the Profibrinolytic Actions of Heparin and Its Fractions , 1985, Seminars in thrombosis and hemostasis.

[6]  J. Verheijen,et al.  Fibrinolytic Activators and Inhibitors in Terminal Renal Insufficiency and in Anephric Patients , 1984, Thrombosis and Haemostasis.

[7]  J. Toohey,et al.  Effect of hemodialysis on contact group of coagulation factors, platelets, and leukocytes. , 1984, The American journal of medicine.

[8]  W. Vollmer,et al.  LONG-TERM SURVIVAL ON DIALYSIS , 1983, The Lancet.

[9]  C. Kluft,et al.  Behaviour and Quantitation of Extrinsic (Tissue-Type) Plasminogen Activator in Human Blood , 1983, Thrombosis and Haemostasis.

[10]  P. Gaffney,et al.  Heparin and a low molecular weight fraction enhances thrombolysis and by this pathway exercises a protective effect against thrombosis. , 1983, Thrombosis research.

[11]  J. Jespersen,et al.  A study of the fibrin plate assay of fibrinolytic agents. Optimal conditions, reproducibility and precision. , 1983, Haemostasis.

[12]  G. Mangiarotti,et al.  Impaired fibrinolysis in uremia: partial and variable correction by four different dialysis regimes. , 1982, Clinical nephrology.

[13]  J. Jespersen,et al.  The use of evacuated glass tubes for collection of blood samples for fibrinolytic assays. , 1982, Thrombosis research.

[14]  J. Jespersen,et al.  Lowering of the dosage of intravenous heparin hemodialysis by priming with subcutaneous heparin. , 1981, Clinical nephrology.

[15]  C. Smith,et al.  The effects of carbon hemoperfusion and hemodialysis on fibrinolysis. , 1980, Transactions - American Society for Artificial Internal Organs.

[16]  C. Kluft.  C1-inactivator-resistant fibrinolytic activity in plasma euglobulin fractions: its relation to vascular activator in blood and its role in euglobulin fibrinolysis. , 1978, Thrombosis research.

[17]  F. Markwardt,et al.  Heparin-induced release of plasminogen activator. , 1977, Haemostasis.

[18]  C. Kluft.  Elimination of inhibition in euglobulin fibrinolysis by use of flufenamate: involvement of C1-inactivator. , 1977, Haemostasis.

[19]  H. Lackner,et al.  Variation in Fibrinolytic Activity After Acute Myocardial Infarction and After the Administration of Oral Anticoagulant Drugs and Intravenous Heparin , 1960, British journal of haematology.

[20]  T. Astrup.  Analytical Review: Fibrinolysis in the Organism , 1956 .